Literature DB >> 33654103

Thalamic morphology predicts the onset of freezing of gait in Parkinson's disease.

Nicholas D'Cruz1, Griet Vervoort2, Sima Chalavi3, Bauke W Dijkstra2, Moran Gilat2, Alice Nieuwboer2.   

Abstract

The onset of freezing of gait (FOG) in Parkinson's disease (PD) is a critical milestone, marked by a higher risk of falls and reduced quality of life. FOG is associated with alterations in subcortical neural circuits, yet no study has assessed whether subcortical morphology can predict the onset of clinical FOG. In this prospective multimodal neuroimaging cohort study, we performed vertex-based analysis of grey matter morphology in fifty-seven individuals with PD at study entry and two years later. We also explored the behavioral correlates and resting-state functional connectivity related to these local volume differences. At study entry, we found that freezers (N = 12) and persons who developed FOG during the course of the study (converters) (N = 9) showed local inflations in bilateral thalamus in contrast to persons who did not (non-converters) (N = 36). Longitudinally, converters (N = 7) also showed local inflation in the left thalamus, as compared to non-converters (N = 36). A model including sex, daily levodopa equivalent dose, and local thalamic inflation predicted conversion with good accuracy (AUC: 0.87, sensitivity: 88.9%, specificity: 77.8%). Exploratory analyses showed that local thalamic inflations were associated with larger medial thalamic sub-nuclei volumes and better cognitive performance. Resting-state analyses further revealed that converters had stronger thalamo-cortical coupling with limbic and cognitive regions pre-conversion, with a marked reduction in coupling over the two years. Finally, validation using the PPMI cohort suggested FOG-specific non-linear evolution of thalamic local volume. These findings provide markers of, and deeper insights into conversion to FOG, which may foster earlier intervention and better mobility for persons with PD.

Entities:  

Year:  2021        PMID: 33654103     DOI: 10.1038/s41531-021-00163-0

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  64 in total

1.  Freezing of gait in patients with advanced Parkinson's disease.

Authors:  N Giladi; T A Treves; E S Simon; H Shabtai; Y Orlov; B Kandinov; D Paleacu; A D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

2.  The major impact of freezing of gait on quality of life in Parkinson's disease.

Authors:  Courtney C Walton; James M Shine; Julie M Hall; Claire O'Callaghan; Loren Mowszowski; Moran Gilat; Jennifer Y Y Szeto; Sharon L Naismith; Simon J G Lewis
Journal:  J Neurol       Date:  2014-10-16       Impact factor: 4.849

3.  Freezing of Gait and Its Levodopa Paradox.

Authors:  Jorik Nonnekes; Matthieu Bereau; Bastiaan R Bloem
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

Review 4.  Freezing of gait: moving forward on a mysterious clinical phenomenon.

Authors:  John G Nutt; Bastiaan R Bloem; Nir Giladi; Mark Hallett; Fay B Horak; Alice Nieuwboer
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

5.  Three simple clinical tests to accurately predict falls in people with Parkinson's disease.

Authors:  Serene S Paul; Colleen G Canning; Catherine Sherrington; Stephen R Lord; Jacqueline C T Close; Victor S C Fung
Journal:  Mov Disord       Date:  2013-02-28       Impact factor: 10.338

6.  Impaired implicit sequence learning in Parkinson's disease patients with freezing of gait.

Authors:  Jochen Vandenbossche; Natacha Deroost; Eric Soetens; Daphné Coomans; Joke Spildooren; Sarah Vercruysse; Alice Nieuwboer; Eric Kerckhofs
Journal:  Neuropsychology       Date:  2013-01       Impact factor: 3.295

Review 7.  Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta-Analyses.

Authors:  Carola Cosentino; Marco Baccini; Martina Putzolu; Diego Ristori; Laura Avanzino; Elisa Pelosin
Journal:  Mov Disord       Date:  2019-12-04       Impact factor: 10.338

8.  Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.

Authors:  Santiago Perez-Lloret; Laurence Negre-Pages; Philippe Damier; Arnaud Delval; Pascal Derkinderen; Alain Destée; Wassilios G Meissner; Ludwig Schelosky; Francois Tison; Olivier Rascol
Journal:  JAMA Neurol       Date:  2014-07-01       Impact factor: 18.302

9.  Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait.

Authors:  Elke Heremans; Evelien Nackaerts; Griet Vervoort; Sanne Broeder; Stephan P Swinnen; Alice Nieuwboer
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 10.  Motor Learning Deficits in Parkinson's Disease (PD) and Their Effect on Training Response in Gait and Balance: A Narrative Review.

Authors:  Markey Olson; Thurmon E Lockhart; Abraham Lieberman
Journal:  Front Neurol       Date:  2019-02-07       Impact factor: 4.003

View more
  3 in total

1.  Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects.

Authors:  Jisoo Kim; Geoffrey S Young; Andrew S Willett; Ariana T Pitaro; Grace F Crotty; Merlyne Mesidor; Kristie A Jones; Camden Bay; Min Zhang; Mel B Feany; Xiaoyin Xu; Lei Qin; Vikram Khurana
Journal:  Cerebellum       Date:  2022-09-26       Impact factor: 3.648

2.  Cerebral blood flow alterations specific to freezing of gait in Parkinson's disease.

Authors:  Shangpei Wang; Tong Wu; Chuan Li; Tieyu Wu; Yinfeng Qian; Cuiping Ren; Yan Qin; Juan Li; Xianzhou Chu; Xianwen Chen; Yongqiang Yu
Journal:  Neurol Sci       Date:  2022-06-20       Impact factor: 3.830

3.  Constructing Prediction Models for Freezing of Gait by Nomogram and Machine Learning: A Longitudinal Study.

Authors:  Kun Xu; Xiao-Xia Zhou; Run-Cheng He; Zhou Zhou; Zhen-Hua Liu; Qian Xu; Qi-Ying Sun; Xin-Xiang Yan; Xin-Yin Wu; Ji-Feng Guo; Bei-Sha Tang
Journal:  Front Neurol       Date:  2021-12-06       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.